These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27199287)

  • 1. Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.
    Ellis KL; Hooper AJ; Burnett JR; Watts GF
    Nat Rev Endocrinol; 2016 Aug; 12(8):467-84. PubMed ID: 27199287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].
    Sobra J
    Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
    de Graaf J; Stalenhoef AF
    Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial combined hyperlipidemia].
    Martin G; Shviro I; Staels B; Auwerx J
    Ann Endocrinol (Paris); 1997; 58(4):283-6. PubMed ID: 9436474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of 4 years' of hypolipemic treatment on the width of the common carotid artery intima in patients with familial hyperlipidemias].
    Spácil J; Ceska R; Petrásek J; Sobra J
    Vnitr Lek; 1997 Nov; 43(11):722-7. PubMed ID: 9650502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
    Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lifestyle contribute to disease severity in patients with inherited lipid disorders?
    Arsenault BJ; Perrot N; Couture P
    Curr Opin Lipidol; 2017 Apr; 28(2):177-185. PubMed ID: 28030378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial combined hyperlipoproteinemia.
    Genest J
    Can J Cardiol; 1991 Mar; 7(2):X-XI. PubMed ID: 2049681
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
    Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
    J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
    de Graaf J; van der Vleuten G; Stalenhoef AF
    Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hyperlipidemia in stroke in the young.
    Bansal BC; Sood AK; Bansal CB
    Stroke; 1986; 17(6):1142-5. PubMed ID: 3810712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New guidelines for screening and management of familial dyslipidemia].
    Brun N; Aubert CE; Nanchen D; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):435-9. PubMed ID: 27089599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia.
    Pedro-Botet J; Climent E; Gabarró N; Millán J
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():43-49. PubMed ID: 34006353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H23-6. PubMed ID: 9717061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.